Idiopathic Short Stature (ISS)Symptoms, Doctors, Treatments, Advances & More
Idiopathic Short Stature (ISS) Overview
Learn About Idiopathic Short Stature (ISS)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Nemours Children’s Health – Wilmington
Judith Ross is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Wilmington, Delaware. Dr. Ross is rated as an Elite provider by MediFind in the treatment of Idiopathic Short Stature (ISS). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses 47 XYY Syndrome, Turner Syndrome, Klinefelter Syndrome, Idiopathic Short Stature (ISS), and Hormone Replacement Therapy (HRT). Dr. Ross is board certified in Pediatrics, Endocrinology, and American Board Of Pediatrics. Dr. Ross is currently accepting new patients.
Werner Blum practices practicing medicine in Giessen, Germany. Mr. Blum is rated as an Elite expert by MediFind in the treatment of Idiopathic Short Stature (ISS). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Idiopathic Short Stature (ISS), Short Stature (Growth Disorders), Hypopituitarism, and Pediatric Growth Hormone Deficiency.
Maki Fukami practices practicing medicine in Tokyo, Japan. Fukami is rated as an Elite expert by MediFind in the treatment of Idiopathic Short Stature (ISS). They are also highly rated in 68 other conditions, according to our data. Their clinical expertise encompasses Russell-Silver Dwarfism, Intersex, Idiopathic Short Stature (ISS), and Short Stature (Growth Disorders).
Summary: This basket trial will enroll prepubertal children and adolescents with clinically diagnosed and genetically confirmed (if applicable) TS, SHOX-D, SGA, or ISS between ages of ≥2 and \<18 years with open growth plates. The purpose of the study is to see how well treatment with once-weekly lonapegsomatropin works compared to treatment with daily somatropin. Approximately 186 participants will be dis...
Summary: Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
